|
Apoptosis
Citations 101-110 of 746 total displayed.
|
Past content
(since May 2000):
|
A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome
- Manuel Del-Rey, Jesus Ruiz-Contreras, Alberto Bosque, Sara Calleja, Jose Gomez-Rial, Ernesto Roldan, Pablo Morales, Antonio Serrano, Alberto Anel, Estela Paz-Artal, and Luis M. Allende
Blood 2006; 108: 1306-1312.
[Abstract]
[Full text]
[PDF]
Mcl-1L cleavage is involved in TRAIL-R1– and TRAIL-R2–mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells
- Emmanuelle Menoret, Patricia Gomez-Bougie, Alexandrine Geffroy-Luseau, Sylvanne Daniels, Philippe Moreau, Steven Le Gouill, Jean-Luc Harousseau, Regis Bataille, Martine Amiot, and Catherine Pellat-Deceunynck
Blood 2006; 108: 1346-1352.
[Abstract]
[Full text]
[PDF]
RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection
- Richard L. Bennett, William L. Blalock, Dean M. Abtahi, Yu Pan, Sue A. Moyer, and W. Stratford May
Blood 2006; 108: 821-829.
[Abstract]
[Full text]
[PDF]
Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance
- Ye Qian, Kara L. Conway, Xiangdong Lu, Heather M. Seitz, Glenn K. Matsushima, and Stephen H. Clarke
Blood 2006; 108: 974-982.
[Abstract]
[Full text]
[PDF]
Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia
- Kensuke Kojima, Marina Konopleva, Teresa McQueen, Susan O'Brien, William Plunkett, and Michael Andreeff
Blood 2006; 108: 993-1000.
[Abstract]
[Full text]
[PDF]
Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2
- Christian Flotho, Elaine Coustan-Smith, Deqing Pei, Shotaro Iwamoto, Guangchun Song, Cheng Cheng, Ching-Hon Pui, James R. Downing, and Dario Campana
Blood 2006; 108: 1050-1057.
[Abstract]
[Full text]
[PDF]
Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells
- Marion Gabillot-Carré, Yves Lepelletier, Martine Humbert, Paulo de Sepuvelda, Nadine Ben Hamouda, Jean Pierre Zappulla, Roland Liblau, Antoine Ribadeau-Dumas, François Machavoine, Sébastien Letard, Cédric Baude, Aurélie Hermant, Ying Yang, Jacques Vargaftig, Christine Bodemer, Emmanuel Morelon, Olivier Lortholary, Christian Recher, Guy Laurent, Michel Dy, Michel Arock, Patrice Dubreuil, and Olivier Hermine
Blood 2006; 108: 1065-1072.
[Abstract]
[Full text]
[PDF]
Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis
- Inna N. Lavrik, Alexander Golks, Simone Baumann, and Peter H. Krammer
Blood 2006; 108: 559-565.
[Abstract]
[Full text]
[PDF]
Gimap4 accelerates T-cell death
- Silke Schnell, Corinne Démollière, Paul van den Berk, and Heinz Jacobs
Blood 2006; 108: 591-599.
[Abstract]
[Full text]
[PDF]
Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells
- Bing Z. Carter, Duncan H. Mak, Wendy D. Schober, Teresa McQueen, David Harris, Zeev Estrov, Randall L. Evans, and Michael Andreeff
Blood 2006; 108: 630-637.
[Abstract]
[Full text]
[PDF]
|
|
